{"id":61659,"date":"2025-07-30T04:05:20","date_gmt":"2025-07-30T02:05:20","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/boston-jury-hits-johnson-johnson-with-record-42m-verdict-in-asbestos-baby-powder-case\/"},"modified":"2025-07-30T04:05:20","modified_gmt":"2025-07-30T02:05:20","slug":"boston-jury-hits-johnson-johnson-with-record-42m-verdict-in-asbestos-baby-powder-case","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/boston-jury-hits-johnson-johnson-with-record-42m-verdict-in-asbestos-baby-powder-case\/","title":{"rendered":"Boston Jury Hits Johnson & Johnson with Record $42M Verdict in Asbestos Baby Powder Case"},"content":{"rendered":"
\n

\nDean Omar Branham Shirley attorneys secure verdict by linking mesothelioma to asbestos in J&J talc products<\/i><\/p>\n

BOSTON–(BUSINESS WIRE)–A Boston jury has sided with Paul and Kathryn Lovell in a lawsuit against cosmetic behemoth Johnson & Johnson (NYSE:JNJ) that asserted Mr. Lovell\u2019s mesothelioma was directly caused by the company\u2019s iconic, asbestos-laced baby powder. The jury awarded $42,609,300, making it what lawyers believe to be the largest mesothelioma verdict in Massachusetts history.<\/p>\n

<\/a>
<\/a><\/p>\n

\nDuring the two-week trial, jurors heard compelling arguments from Dean Omar Branham Shirley attorneys Aaron Chapman<\/a> and Danny Kraft<\/a>, who detailed how Johnson & Johnson and its affiliated entities knowingly concealed for decades the health risks associated with their talc products.<\/p>\n

\nThe attorneys presented internal documents showing the company\u2019s awareness of asbestos contamination, its failure to adopt safer alternatives and systematic manipulation of scientific testing methods. The jury agreed that the company not only failed to warn consumers, but also actively misled the public and regulators by suppressing test results and spreading false assurances about product safety.<\/p>\n

\n“This verdict is not just about Paul Lovell. It’s about every consumer who was told these products were safe,\u201d said Mr. Chapman. \u201cFor years, Johnson & Johnson ignored its own internal warnings and scientific evidence about the presence of asbestos in its talc. The jury has sent a strong message: Corporate misconduct will not be tolerated.\u201d<\/p>\n

\nMr. Lovell, 69, and his wife have been married for 45 years. A father of four, he used Johnson\u2019s Baby Powder on himself and his children, trusting it was safe. They have lived in the same home in Melrose, Massachusetts, for decades.<\/p>\n

\n\u201cPaul never worked in a factory, never used joint compound, and never had any occupational exposure to asbestos. Instead, like untold millions of Americans, he was a lifelong user of J&J\u2019s Baby Powder,\u201d said Mr. Kraft. \u201cHe trusted the product on himself and on his children.\u201d<\/p>\n

\nThe jury found the company\u2019s actions amounted to negligence and breach of warranty. The Lovell family was also represented by Leslie-Anne Taylor<\/a> of Thornton Law Firm LLP.<\/p>\n

\nThe case is Paul Lovell and Kathryn Lovell v. Johnson & Johnson<\/i>, Civil Action No. 21-2086, filed in Middlesex County Superior Court in Massachusetts.<\/p>\n

\nDean Omar Branham Shirley, LLP, is a nationally recognized trial firm that handles cases across the country for individuals who have suffered catastrophic injuries or have died as a result of irresponsible conduct of others. For more information, please visit http:\/\/www.dobslegal.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contact:
\n
<\/b>BeLynn Hollers
\n
800-559-4534
\n
belynn@androvett.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Dean Omar Branham Shirley attorneys secure verdict by linking mesothelioma to asbestos in J&J talc products BOSTON–(BUSINESS WIRE)–A Boston jury has sided with Paul and Kathryn Lovell in a lawsuit against cosmetic behemoth Johnson & Johnson (NYSE:JNJ) that asserted Mr. Lovell\u2019s mesothelioma was directly caused by the company\u2019s iconic, asbestos-laced baby powder. The jury awarded … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61659","6":"format-standard","7":"category-industry"},"yoast_head":"\nBoston Jury Hits Johnson & Johnson with Record $42M Verdict in Asbestos Baby Powder Case - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/boston-jury-hits-johnson-johnson-with-record-42m-verdict-in-asbestos-baby-powder-case\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Boston Jury Hits Johnson & Johnson with Record $42M Verdict in Asbestos Baby Powder Case - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Dean Omar Branham Shirley attorneys secure verdict by linking mesothelioma to asbestos in J&J talc products BOSTON–(BUSINESS WIRE)–A Boston jury has sided with Paul and Kathryn Lovell in a lawsuit against cosmetic behemoth Johnson & Johnson (NYSE:JNJ) that asserted Mr. Lovell\u2019s mesothelioma was directly caused by the company\u2019s iconic, asbestos-laced baby powder. The jury awarded ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/boston-jury-hits-johnson-johnson-with-record-42m-verdict-in-asbestos-baby-powder-case\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-30T02:05:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250729974759\/en\/2537897\/22\/Dobs_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/boston-jury-hits-johnson-johnson-with-record-42m-verdict-in-asbestos-baby-powder-case\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/boston-jury-hits-johnson-johnson-with-record-42m-verdict-in-asbestos-baby-powder-case\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Boston Jury Hits Johnson & Johnson with Record $42M Verdict in Asbestos Baby Powder Case\",\"datePublished\":\"2025-07-30T02:05:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/boston-jury-hits-johnson-johnson-with-record-42m-verdict-in-asbestos-baby-powder-case\\\/\"},\"wordCount\":442,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/boston-jury-hits-johnson-johnson-with-record-42m-verdict-in-asbestos-baby-powder-case\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250729974759\\\/en\\\/2537897\\\/22\\\/Dobs_logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/boston-jury-hits-johnson-johnson-with-record-42m-verdict-in-asbestos-baby-powder-case\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/boston-jury-hits-johnson-johnson-with-record-42m-verdict-in-asbestos-baby-powder-case\\\/\",\"name\":\"Boston Jury Hits Johnson & Johnson with Record $42M Verdict in Asbestos Baby Powder Case - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/boston-jury-hits-johnson-johnson-with-record-42m-verdict-in-asbestos-baby-powder-case\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/boston-jury-hits-johnson-johnson-with-record-42m-verdict-in-asbestos-baby-powder-case\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250729974759\\\/en\\\/2537897\\\/22\\\/Dobs_logo.jpg\",\"datePublished\":\"2025-07-30T02:05:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/boston-jury-hits-johnson-johnson-with-record-42m-verdict-in-asbestos-baby-powder-case\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/boston-jury-hits-johnson-johnson-with-record-42m-verdict-in-asbestos-baby-powder-case\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/boston-jury-hits-johnson-johnson-with-record-42m-verdict-in-asbestos-baby-powder-case\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250729974759\\\/en\\\/2537897\\\/22\\\/Dobs_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250729974759\\\/en\\\/2537897\\\/22\\\/Dobs_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/boston-jury-hits-johnson-johnson-with-record-42m-verdict-in-asbestos-baby-powder-case\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Boston Jury Hits Johnson & Johnson with Record $42M Verdict in Asbestos Baby Powder Case\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Boston Jury Hits Johnson & Johnson with Record $42M Verdict in Asbestos Baby Powder Case - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/boston-jury-hits-johnson-johnson-with-record-42m-verdict-in-asbestos-baby-powder-case\/","og_locale":"en_US","og_type":"article","og_title":"Boston Jury Hits Johnson & Johnson with Record $42M Verdict in Asbestos Baby Powder Case - Pharma Trend","og_description":"Dean Omar Branham Shirley attorneys secure verdict by linking mesothelioma to asbestos in J&J talc products BOSTON–(BUSINESS WIRE)–A Boston jury has sided with Paul and Kathryn Lovell in a lawsuit against cosmetic behemoth Johnson & Johnson (NYSE:JNJ) that asserted Mr. Lovell\u2019s mesothelioma was directly caused by the company\u2019s iconic, asbestos-laced baby powder. The jury awarded ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/boston-jury-hits-johnson-johnson-with-record-42m-verdict-in-asbestos-baby-powder-case\/","og_site_name":"Pharma Trend","article_published_time":"2025-07-30T02:05:20+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250729974759\/en\/2537897\/22\/Dobs_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/boston-jury-hits-johnson-johnson-with-record-42m-verdict-in-asbestos-baby-powder-case\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/boston-jury-hits-johnson-johnson-with-record-42m-verdict-in-asbestos-baby-powder-case\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Boston Jury Hits Johnson & Johnson with Record $42M Verdict in Asbestos Baby Powder Case","datePublished":"2025-07-30T02:05:20+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/boston-jury-hits-johnson-johnson-with-record-42m-verdict-in-asbestos-baby-powder-case\/"},"wordCount":442,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/boston-jury-hits-johnson-johnson-with-record-42m-verdict-in-asbestos-baby-powder-case\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250729974759\/en\/2537897\/22\/Dobs_logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/boston-jury-hits-johnson-johnson-with-record-42m-verdict-in-asbestos-baby-powder-case\/","url":"https:\/\/pharma-trend.com\/en\/boston-jury-hits-johnson-johnson-with-record-42m-verdict-in-asbestos-baby-powder-case\/","name":"Boston Jury Hits Johnson & Johnson with Record $42M Verdict in Asbestos Baby Powder Case - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/boston-jury-hits-johnson-johnson-with-record-42m-verdict-in-asbestos-baby-powder-case\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/boston-jury-hits-johnson-johnson-with-record-42m-verdict-in-asbestos-baby-powder-case\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250729974759\/en\/2537897\/22\/Dobs_logo.jpg","datePublished":"2025-07-30T02:05:20+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/boston-jury-hits-johnson-johnson-with-record-42m-verdict-in-asbestos-baby-powder-case\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/boston-jury-hits-johnson-johnson-with-record-42m-verdict-in-asbestos-baby-powder-case\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/boston-jury-hits-johnson-johnson-with-record-42m-verdict-in-asbestos-baby-powder-case\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250729974759\/en\/2537897\/22\/Dobs_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250729974759\/en\/2537897\/22\/Dobs_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/boston-jury-hits-johnson-johnson-with-record-42m-verdict-in-asbestos-baby-powder-case\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Boston Jury Hits Johnson & Johnson with Record $42M Verdict in Asbestos Baby Powder Case"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61659","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61659"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61659\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61659"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61659"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61659"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}